| SNP ID |
Visualize variation |
Clinical significance |
Consequence |
| rs61733392 |
G>C |
Conflicting-interpretations-of-pathogenicity |
Non coding transcript variant, coding sequence variant, missense variant |
| rs778899140 |
T>C |
Pathogenic, likely-pathogenic |
Non coding transcript variant, missense variant, 5 prime UTR variant, coding sequence variant |
| rs875989839 |
C>G |
Pathogenic |
5 prime UTR variant, coding sequence variant, missense variant, non coding transcript variant |
| rs875989840 |
A>G |
Pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
| rs875989841 |
A>G |
Pathogenic |
5 prime UTR variant, coding sequence variant, missense variant, non coding transcript variant |
| rs1332740547 |
G>A,T |
Likely-pathogenic |
5 prime UTR variant, coding sequence variant, synonymous variant, missense variant, non coding transcript variant |
| rs1554258695 |
A>C |
Likely-pathogenic, pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
| rs1583275773 |
G>A |
Likely-pathogenic |
Stop gained, coding sequence variant, 5 prime UTR variant, non coding transcript variant |
|
|
UniProt ID
Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
|
Q9Y233 |
| Protein name |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17) |
| Protein function |
Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides (PubMed:10373451, PubMed:10393245, PubMed:16330539, PubMed:17389385, PubMed:27058447). Can hydrolyze both cAMP and cGMP, but has higher affin |
| PDB |
2OUN
, 2OUP
, 2OUQ
, 2OUR
, 2OUS
, 2OUU
, 2OUV
, 2OUY
, 2WEY
, 2Y0J
, 2ZMF
, 3SN7
, 3SNI
, 3SNL
, 3UI7
, 3UUO
, 3WI2
, 3WS8
, 3WS9
, 3WYK
, 3WYL
, 3WYM
, 4AEL
, 4AJD
, 4AJF
, 4AJG
, 4AJM
, 4BBX
, 4DDL
, 4DFF
, 4FCB
, 4FCD
, 4HEU
, 4HF4
, 4LKQ
, 4LLJ
, 4LLK
, 4LLP
, 4LLX
, 4LM0
, 4LM1
, 4LM2
, 4LM3
, 4LM4
, 4MRW
, 4MRZ
, 4MS0
, 4MSA
, 4MSC
, 4MSE
, 4MSH
|
| Family and domains |
Pfam
| Accession |
ID |
Position in sequence |
Description |
Type |
| PF01590 |
GAF |
91 → 235 |
GAF domain |
Domain |
| PF01590 |
GAF |
266 → 412 |
GAF domain |
Domain |
| PF00233 |
PDEase_I |
514 → 746 |
|
Domain |
|
| Tissue specificity |
TISSUE SPECIFICITY: Abundant in the putamen and caudate nucleus regions of brain and testis, moderately expressed in the thyroid gland, pituitary gland, thalamus and cerebellum. {ECO:0000269|PubMed:10373451, ECO:0000269|PubMed:27058447}. |
| Sequence |
|
| Sequence length |
779 |
| Interactions |
View interactions |
|
|
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| Clear cell carcinoma of kidney |
Benign |
rs61733391 |
RCV005911662 |
| Familial cancer of breast |
Likely benign |
rs556354100 |
RCV005869855 |
| Gastric cancer |
Benign; Likely benign |
rs61733392 |
RCV005899705 |
| Malignant lymphoma, large B-cell, diffuse |
Likely benign |
rs556354100 |
RCV005869857 |
| PDE10A-related disorder |
Likely benign; Benign; Uncertain significance; Conflicting classifications of pathogenicity |
rs1173003721, rs77122094, rs199680048, rs140098147, rs2483700133, rs2533689494, rs79199585, rs61733392, rs143718875, rs148845227, rs6924943, rs111737394, rs761017460, rs141863025, rs754387675 |
RCV003965893 RCV003931076 RCV003943585 RCV003961242 RCV003412453 RCV003944188 RCV003919529 RCV003915343 RCV003936068 RCV003936143 RCV003918444 RCV003958073 RCV003902892 RCV003953389 RCV003953414 |
| Sarcoma |
Benign; Likely benign |
rs61733392 |
RCV005899704 |
| Thyroid cancer, nonmedullary, 1 |
Benign; Likely benign |
rs61733392 |
RCV005899706 |
| Uveal melanoma |
Likely benign; Benign |
rs556354100, rs61733392 |
RCV005869856 RCV005899703 |
|
|
|